| [1] Abbott R D, Petrovitch H, White L R, et al. Frequency of bowel movements and the future risk of Parkinson' s disease [J]. Neurology, 2001, 57 (3): 456-462.[2] Claassen D O, Josephs K A, Ahlskog J E, et al. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century [J]. Neurology, 2010, 75 (6): 494-499.[3] Liu Y, Qiang M, Wei Y, et al. A novel molecular mechanism for nitrated α-synuclein-induced cell death [J]. J Mol Cell Biol, 2011, 3 (4): 239-249.[4] Fujiwara H, Hasegawa M, Dohmae N, et al. α-Synuclein is phosphorylated in synucleinopathy lesions [J]. Nat Cell Biol, 2002, 4 (2): 160-164.[5] Mbefo M K, Paleologou K E, Boucharaba A, et al. Phosphorylation of α-synucleins by members of the Polo-like kinase family [J]. J Biol Chem, 2010, 285 (4): 2807-2822.[6] Giasson B I, Duda J E, Murray I V, et al. Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions [J]. Science, 2000, 290 (5493): 985-989.[7] Hodara R, Norris EH, Giasson BI, et al. Functional consequences of α-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation [J]. J Biol Chem, 2004, 279 (46): 47746-47753.[8] Paleologou K E, Schmid A W, Rospigliosi C C, et al. Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein [J]. J Biol Chem, 2008, 283 (24): 16895-16905.[9] Kirkitadze M D, Bitan G, Teplow D B. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies [J]. J Neurosci Res, 2002, 69 (5): 567-577.[10] Yu S, Li X, Liu G, et al. Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody [J]. Neuroscience, 2007, 145 (2): 539-555.[11] Li W, Lesuisse C, Xu Y, et al. Stabilization of α-synuclein protein with aging and familial Parkinson's disease-linked A53T mutation [J]. J Neurosci, 2004, 24 (33): 7400-7409.[12] Chu Y, Kordower J H. Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson's disease [J]. Neurobiol Dis, 2007, 25 (1): 134-149.[13] Xuan Q, Xu S L, Lu D H, et al. Increase expression of α-synuclein in aged human brain associated with neuromelanin accumulation [J]. J Neural Transm, 2011, 118(11): 1575-1583.[14] 李昕, 杨巍巍,李雁,等. 一种检测帕金森患者血浆促进α-突触核蛋白寡聚体形成能力的方法 [J]. 首都医科大学学报,2013,34(6):830-831.[15] 尹娜, 陈予东,李昕,等. 帕金森病患者血浆增强α-突触核蛋白寡聚体形成 [J]. 首都医科大学学报,2013,34(6): 840-843. |
